China-based Concord Medical Services Holdings has signed an agreement to sell its 52% equity stake in Chang’an Hospital for CNY398m ($64.8m).

Concord Medical Services Holdings signed the agreements through its subsidiaries.

The deal includes the sale of ownership interests in Chang’an CMS International Cancer Center (CCICC), a specialised cancer diagnosis and treatment centre, established between Concord Medical and Chang’an Hospital in July 2010.

Concord Medical Services Holdings chairman Dr Jianyu Yang said: "Our divestment of Chang’an Hospital allows Concord to fully concentrate on our efforts to build a nationwide network of diagnosis and treatment centres and specialised cancer hospitals.

"The deal includes the sale of ownership interests in Chang’an CMS International Cancer Center (CCICC), a specialised cancer diagnosis and treatment centre, established between Concord Medical and Chang’an Hospital in July 2010."

"The proceeds from this transaction will be used to fund the construction of our current projects, as well as to pay off some current debt.

"Going forward, we expect to open five free-standing radiotherapy cancer centres and to begin construction on one to two level-III premium cancer specialty hospitals in 2015."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Concord Medical will continue to support Chang’an Hospital on hospital management, oncology department and talent training after the transaction closes.

Subject to relevant government approvals, the transaction is expected to be completed by the end of 2014. Concord Medical operates specialty cancer hospitals, as well as radiotherapy and diagnostic imaging centres in China.

The company’s network includes 141 centres with 81 hospital partners that spans 56 cities and 25 provinces and administrative regions in the country, as of 30 September 2014.